You searched for "therapeutics"

422 results found

In this issue...Inner Ear Therapeutics

Emma Stapleton, MBChB, FRCS (ORL-HNS), Consultant Otolaryngologist, Cochlear Implant and Skull Base Surgeon, Manchester Royal Infirmary, UK. E: emmastapleton@doctors.org.ukTwitter: @otolaryngolofox Ralph Holme, Director of Research and Insight, RNID, UK. Ralph. E: Holme@rnid.org.uk W: www.rnid.org.uk For Mar/Apr 2022, we sang the...

Cochlear implants and therapeutics: a natural partnership?

Global awareness of cochlear implants as a solution for hearing loss is slowly increasing and gaining acceptance. The potential for combining cochlear implants with inner ear therapeutics is immense, with promise in several areas. This article takes us on a...

Mind the gap – developing a sustainable pipeline for hearing therapeutics

In this article, the authors describe three key challenges faced in developing hearing therapeutics. Collaboration between companies, sectors and disciplines will be key to finding solutions. The unmet need for therapies for hearing loss grows apace, with prevalence rising across...

A drug to prevent hearing loss caused by ototoxic therapeutics

This editorial briefly highlights the progress made in discovering a compound named ORC-13661, which shows the potential to alter the response of hair cells to ototoxic medication. In the late 1980s, inner hair cells that were lost secondary to noise...

Inner Ear Disorders Therapeutics Summit

There is a tremendous amount of activity at the moment about pharmaceutical therapies for inner ear disorders: the main focus is upon hearing loss, but tinnitus is also strongly evident. This meeting was an ambitious and successful attempt to draw...

3rd International Symposium on Inner Ear Therapeutics

L’Institut de l’Audition (Centre Pasteur, Paris) and the International Society for Inner Ear Therapeutics (ISIET), with de collaboration with ENT-HNS Moroccan Collège (CEMORL), are organising the 3rd International Symposium on Inner Ear Therapeutics entitled ‘Inner Ear Therapeutics: Updates and Challenges...

3rd Annual Inner Ear Disorders Therapeutics Summit

The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss. The 3rd Inner Ear...

Team proves secure pathway to the inner ear

An international team of surgeons and scientists has, for the first time, validated safe surgical access to the central core of the human cochlea.

Do you really like me? Is it, Is it therapy?

Therapeutic alliance describes what happens in the interactions and relationships between the client and the therapist. There is evidence from mental health literature that a therapeutic alliance can have a significant impact on outcomes. A negative alliance can lead to...

Student education grants for hearing conference

Frequency Therapeutics is offering student sponsorship for a second year to the Future of Hearing Healthcare Conference. The grant is open to any students currently pursuing a graduate-level degree (master's or doctorate) in audiology or a related discipline.

What we need to know about the new frontier of inner ear therapies

This is an interesting and topical review of the emerging biotechnology and pharmaceutical solutions for hearing loss and related conditions such as tinnitus. This paper suggests we are on the cusp of a very large step-change in the way we...